Tamaki Suganuma

Dr. Tamaki Suganuma

Stowers Institute for Medical Research, Kansas City, Kansas, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2011 in Annual Review of Biochemistry
Verified
Journal Article
Closed access
TSTamaki Suganuma
Tamaki Suganuma
JWJerry L. Workman
Jerry L. Workman
Alterations of chromatin structure have been shown to be crucial for response to cell signaling and for programmed gene expression in development. Posttranslational histone modifications influence changes in chromatin structure both directly and by targeting or activating chromatin-remodeling complexes. Histone modifications intersect with cell signaling pathways to control gene expression and can act combinatorially to enforce or reverse epigenetic marks in chromatin. Through their recognition by protein complexes with enzymatic activities cross talk is established between different modifications and with other epigenetic pathways, including noncoding RNAs (ncRNAs) and DNA methylation. Here, we review the functions of histone modifications and their exploitation in the programming of gene expression during several events in development.

1 November 2015 in Molecular Cell
Verified
Journal Article
Closed access
SLShanshan Li
Shanshan Li
SSSelene K. Swanson
Selene K. Swanson
MGMadelaine Gogol
Madelaine Gogol
LFLaurence Florens
Laurence Florens
MWMichael P. Washburn
Michael P. Washburn
TSTamaki Suganuma
Tamaki Suganuma

20 June 2018 in Annual Review of Biochemistry
Verified
Journal Article
Closed access
TSTamaki Suganuma
Tamaki Suganuma
JWJerry L. Workman
Jerry L. Workman
Chromatin is a mighty consumer of cellular energy generated by metabolism. Metabolic status is efficiently coordinated with transcription and translation, which also feed back to regulate metabolism. Conversely, suppression of energy utilization by chromatin processes may serve to preserve energy resources for cell survival. Most of the reactions involved in chromatin modification require metabolites as their cofactors or coenzymes. Therefore, the metabolic status of the cell can influence the spectra of posttranslational histone modifications and the structure, density and location of nucleosomes, impacting epigenetic processes. Thus, transcription, translation, and DNA/RNA biogenesis adapt to cellular metabolism. In addition to dysfunctions of metabolic enzymes, imbalances between metabolism and chromatin activities trigger metabolic disease and life span alteration. Here, we review the synthesis of the metabolites and the relationships between metabolism and chromatin function. Furthermore, we discuss how the chromatin response feeds back to metabolic regulation in biological processes.

25 June 2018 in eLife
Verified
Journal Article
Open access
SOSeunghee Oh
Seunghee Oh
TSTamaki Suganuma
Tamaki Suganuma
MGMadelaine M Gogol
Madelaine M Gogol
JWJerry L Workman
Jerry L Workman
Upon nutritional stress, the metabolic status of cells is changed by nutrient signaling pathways to ensure survival. Altered metabolism by nutrient signaling pathways has been suggested to influence cellular lifespan. However, it remains unclear how chromatin regulation is involved in this process. Here, we found that histone H3 threonine 11 phosphorylation (H3pT11) functions as a marker for nutritional stress and aging. Sch9 and CK2 kinases cooperatively regulate H3pT11 under stress conditions. Importantly, H3pT11 defective mutants prolonged chronological lifespan (CLS) by altering nutritional stress responses. Thus, the phosphorylation of H3T11 by Sch9 and CK2 links a nutritional stress response to chromatin in the regulation of CLS.

1 June 2013 in Current Opinion in Cell Biology
Verified
Journal Article
Closed access
TSTamaki Suganuma
Tamaki Suganuma
JWJerry L. Workman
Jerry L. Workman

1 August 2018 in Cell Reports
Verified
Journal Article
Open access
TSTamaki Suganuma
Tamaki Suganuma
SSSelene K. Swanson
Selene K. Swanson
MGMadelaine Gogol
Madelaine Gogol
TGTimothy J. Garrett
Timothy J. Garrett
JCJuliana Conkright-Fincham
Juliana Conkright-Fincham
JWJerry L. Workman
Jerry L. Workman
Metabolic disorder has been suggested to underlie Alzheimer's disease (AD). However, the decisive molecular linkages remain unclear. We discovered that human Molybdopterin Synthase Associating Complex, MPTAC, promotes sulfur amino acid catabolism to prevent oxidative damage from excess sulfur amino acids, which, in turn, advances fatty acid oxidation and acetyl coenzyme A (acetyl-CoA) synthesis. The association of MPTAC with Protein arginine (R) Methyltransferase 5 (PRMT5) complex and small nuclear ribonucleoprotein (SNRP) splicing factors enables SNRPs to sense metabolic states through their methylation. This promotes the splicing fidelity of amyloid precursor protein (APP) pre-mRNA and proper APP fragmentation, abnormalities of which have been observed in the platelets of AD patients. The functions of MPTAC are crucial to maintain expression of drebrin 1, which is required for synaptic plasticity, through prevention from oxidative damage. Thus, adjustment of sulfur amino acid catabolism by MPTAC prevents events that occur early in the onset of AD.